Mölnlycke Health Care Publishes Annual Report for 2024

GOTENBURG, Sweden—Mölnlycke, a Swedish medical device company, released its 2024 annual report. The report was prepared in accordance with Global Reporting Initiative (GRI) standards, in addition to the Taskforce on Climate related Financial Disclosures (TCFD) framework. 

“We are transparent about our impact on environment, people and society. Each year, we report on results and performance in the integrated Annual Report,” the company said. 

Additionally, the report has been structured to align with the Corporate Sustainability Reporting Directive (CSRD) format and requirements, though full compliance has not yet been achieved, Mölnlycke said. 

“In 2024, we reached the milestone of EUR 2 billion in annual sales for the first time,” said Zlatko Rihter, chief executive officer. “Our strong financial position and continued growth allow us to direct our future and continued investments. At the same time, it is clear that our strategy and previous investments have paid off, enabling close relationships with our customers working alongside them to handle the challenges of health care today. 

“A heartfelt thank you to all who have supported us during the year—our dedicated people, our valued customers and our committed owners,” Rihter said. “Together we continue our quest to revolutionise care for people and planet. No matter what changes lie ahead.”

For the full report, visit molnlycke.com/corporate/about/reports.